InvestorsHub Logo
Followers 62
Posts 1712
Boards Moderated 0
Alias Born 08/08/2005

Re: jakedogman1 post# 277064

Monday, 10/24/2016 10:16:40 AM

Monday, October 24, 2016 10:16:40 AM

Post# of 346376
QUOTE: "...we seek to advance the program though a pharmaceutical or biotechnology partner."

This was the final sentence of today's PR. Peregrine is serving tasty hors d'oeuvres through continuing pre-clinical studies with various downstream immunotherapies combined with Bavi. MSK is also exploring anti-PS pre-clinical combinations.

Currently, clinical work is being facilitated through NCCN.

QUOTE: "...we seek to advance the program though a pharmaceutical or biotechnology partner."

A table is set.

IMO

sunstar
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News